| |
Carvedilol group (N = 25)
|
Nebivolol group (N = 18)
|
P value
|
|---|
|
Age
|
50.5 ± 10.5
|
50.9 ± 9.6
|
0.89
|
|
Wt (kg )
|
83.3 ± 12
|
81.4 ± 10
|
0.58
|
|
BMI(kg/m2)
|
37.0 ± 6.1
|
36.8 ± 4.3
|
0.9
|
|
Waist circum(cm )
|
118.6 ± 10.5
|
117.3 ± 9.9
|
0.68
|
|
Male gender
|
14 (56%)
|
10 (55.6%)
|
o.8
|
|
Smokers
|
8 (33%)
|
4 (22.2%)
|
0.48
|
|
TG (mg/dl)
|
132 ± 4.5
|
134 ± 3.5
|
0.12
|
|
HDL(mg/dl)
|
38 ± 6.2
|
39 ± 5.3
|
0.59
|
|
Uric acid(mg/dl)
|
8.1 ± 2.6
|
8.0 ± 2.3
|
0.89
|
|
Hb% (gm)
|
13.5 ± 1.2
|
13.0 ± 2.1
|
0.36
|
|
Medications
| | | |
|
Loop diuretic
|
17 (68%)
|
12 (66.7%)
|
0.93
|
|
Aldosterone blocker
|
15 (60%)
|
5 (27.8%)
|
0.036*
|
|
RAS blocker
|
23 (92%)
|
17 (94.4%)
|
0.99
|
|
Digoxin
|
6 (24%)
|
4 (22.2%)
|
0.99
|
|
ASA
|
19 (76%)
|
14 (77.8%)
|
0.99
|
- ASA aspirin, BMI body mass index, HB hemoglobin, HDL high-density lipoprotein, RAS renin-angiotensin-system, TG triglyceride
- *P is significant
